Pfizer’s longtime official Maddaluna is retiring as EVP, Thomas Willemsen will lead GSK China, Taro taps Sun Pharma CFO as new CEO. Plus more hirings, firings…

After getting off its $100 million-plus IPO in the summer, gene editing biotech Intellia Therapeutics is getting ready for human tests of its preclinical…

Caltech researchers have shown in mouse models that gut bacteria can encourage the progression of some Parkinson’s disease hallmarks.

A litmus test of President-elect Donald Trump's plans for the FDA will come when the agency's commissioner hands in his resignation letter in the…

Facebook and Napster billionaire Sean Parker has seen his Institute for Cancer Immunotherapy join forces with the Cancer Research Institute (CRI) to work on…

The House of Representatives has voted overwhelmingly to pass the 21st Century Cures Act, a contentious piece of legislation with implications for FDA.

AstraZeneca has penned a pact to develop bicyclic peptides with Bicycle Therapeutics.

CAR-T biotech Bluebird Bio has released topline data for its experimental med bb2121 in heavily pretreated multiple myeloma in a small, positive study that has…